Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Benderly

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
The American Journal of Cardiology|December 23, 2008
Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial)Ilan Goldenberg, Michal Benderly, Roy Sidi, et al.
Cardiovascular Diabetology|November 25, 2003
Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitusAlexander Tenenbaum, Enrique Z Fisman, Ehud Schwammenthal, et al.
European Journal of Endocrinology|December 31, 2005
Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucoseHilla Knobler, Michal Benderly, Valentina Boyko, et al.
Journal of the American Heart Association|April 17, 2024
Arrhythmia Burden Among Adult Patients With Congenital Heart Disease: A Population-Based StudyNili Schamroth Pravda, Ofra Kalter-Leibovici, Amiram Nir, et al.
Coronary Artery Disease|July 18, 2006
Decrease in triglyceride level by bezafibrate is related to reduction of recurrent coronary events: a Bezafibrate Infarction Prevention substudyMoti Haim, Michal Benderly, Valentina Boyko, et al.
Harefuah|June 30, 2006
[Trends in management, morbidity and mortality of patients with acute myocardial infarction hospitalized in the last decade]Hanoch Hod, Shmuel Gotlieb, Manfred Green, et al.
Archives of Internal Medicine|April 12, 2006
Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrateAlexander Tenenbaum, Enrique Z Fisman, Valentina Boyko, et al.
International Journal of Cardiology|March 1, 2006
CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart diseaseDavid Tanne, Moti Haim, Uri Goldbourt, et al.
The American Journal of Cardiology|June 21, 2006
Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarctionEnrique Z Fisman, Michal Benderly, Ricardo J Esper, et al.
The American Journal of Cardiology|April 3, 2007
Safety and efficacy of the FilterWire EZ in acute ST-segment elevation myocardial infarctionVictor Guetta, Morris Mosseri, Michael Shechter, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
The American Journal of Cardiology|December 23, 2008
Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial)Ilan Goldenberg, Michal Benderly, Roy Sidi, et al.
Cardiovascular Diabetology|November 25, 2003
Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitusAlexander Tenenbaum, Enrique Z Fisman, Ehud Schwammenthal, et al.
European Journal of Endocrinology|December 31, 2005
Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucoseHilla Knobler, Michal Benderly, Valentina Boyko, et al.
Journal of the American Heart Association|April 17, 2024
Arrhythmia Burden Among Adult Patients With Congenital Heart Disease: A Population-Based StudyNili Schamroth Pravda, Ofra Kalter-Leibovici, Amiram Nir, et al.
Coronary Artery Disease|July 18, 2006
Decrease in triglyceride level by bezafibrate is related to reduction of recurrent coronary events: a Bezafibrate Infarction Prevention substudyMoti Haim, Michal Benderly, Valentina Boyko, et al.
Harefuah|June 30, 2006
[Trends in management, morbidity and mortality of patients with acute myocardial infarction hospitalized in the last decade]Hanoch Hod, Shmuel Gotlieb, Manfred Green, et al.
Archives of Internal Medicine|April 12, 2006
Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrateAlexander Tenenbaum, Enrique Z Fisman, Valentina Boyko, et al.
International Journal of Cardiology|March 1, 2006
CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart diseaseDavid Tanne, Moti Haim, Uri Goldbourt, et al.
The American Journal of Cardiology|June 21, 2006
Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarctionEnrique Z Fisman, Michal Benderly, Ricardo J Esper, et al.
The American Journal of Cardiology|April 3, 2007
Safety and efficacy of the FilterWire EZ in acute ST-segment elevation myocardial infarctionVictor Guetta, Morris Mosseri, Michael Shechter, et al.
Pageof 5